Trial site
Josephson Wallack Munshower Neurology, PC
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease10 trials
- Multiple sclerosis5 trials
- Frontotemporal dementia1 trial
- Migraine1 trial
- Mild cognitive impairment1 trial
- Myasthenia gravis1 trial
- Phase
- Phase 312 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting5 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Novartis Pharmaceuticals2 trials
- Actelion1 trial
- Bristol-Myers Squibb1 trial
- Cognito Therapeutics, Inc.1 trial
- and 6 more
Running trials
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Migraine1 recruiting
- Myasthenia gravis1 recruiting
Closed trials
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Completed
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026